Total sales growth (fiscal Q4, period ended Jan. 31, 2026) -- 11%, on top of 10% growth in the prior year, demonstrating consecutive double-digit quarterly increases. Adjusted EPS (fiscal Q4) -- $4.99 ...

Gross margin -- 41% in the quarter (down 8.8 percentage points year over year), and 44.5% for the year; Q4 was below the long ...

Q4 2025 Earnings Call February 26, 2026 11:00 AM ESTCompany ParticipantsChad Paris - CFO & TreasurerGregory S.

NFL teams looking for edge rusher help are in good shape this offseason; the free agent and draft classes have options. But ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.